Indirubin Suppresses Ovarian Cancer Cell Viabilities Through the STAT3 Signaling Pathway
Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s174613
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Informa UK Limited